Clinical Trial Update: Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring whether anakinra can reduce secondary brain damage after spontaneous intracerebral hemorrhage; sponsor Radboud University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: UNKNOWN